Darzalex

Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson
Fierce Pharma
Wed, 01/24/24 - 10:33 am
JNJ
Darzalex
Genmab
legal
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Tue, 04/25/23 - 10:28 am
Genmab
JNJ
Janssen
Darzalex
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
JNJ
Janssen
clinical trials
Darzalex
Revlimid
Velcade
Multiple Myeloma
The patent winter is coming
EP Vantage
Wed, 05/25/22 - 10:41 am
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight
Fierce Pharma
Fri, 04/8/22 - 10:22 am
JNJ
Genmab
Darzalex
Multiple Myeloma
drug royalties
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
Fierce Pharma
Sun, 12/12/21 - 11:33 pm
ASH2021
Sanofi
JNJ
Sarclisa
Darzalex
Multiple Myeloma
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
Thu, 12/2/21 - 10:57 am
JNJ
Sanofi
Multiple Myeloma
Sarclisa
Kyprolis
Darzalex
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
EP Vantage
Wed, 09/29/21 - 10:58 am
AL amyloidosis
Darzalex
AstraZeneca
clinical trials
CAEL-101
Caelum Biosciences
EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data
Fierce Pharma
Mon, 06/14/21 - 10:27 am
JNJ
Darzalex
Multiple Myeloma
Sanofi
Sarclisa
EHA
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Pharmaforum
Fri, 11/13/20 - 12:11 pm
Janssen
Multiple Myeloma
Darzalex
EMA
FDA
J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication
BioSpace
Thu, 10/22/20 - 11:01 pm
JNJ
Genmab
clinical trials
Darzalex
Multiple Myeloma
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Fierce Pharma
Thu, 09/24/20 - 11:32 pm
JNJ
Darzalex
Genmab
Halozyme
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Wed, 09/23/20 - 10:22 am
Genmab
JNJ
Janssen
Darzalex
arbitration
Multiple Myeloma
J&J adds yet another multiple myeloma regimen to the Darzalex label as Sanofi rival jumps in
Endpoints
Fri, 08/21/20 - 12:32 pm
JNJ
Darzalex
FDA
Multiple Myeloma
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
Endpoints
Mon, 06/15/20 - 10:51 am
EHA
JNJ
clinical trials
Darzalex
AL amyloidosis
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
Fierce Pharma
Sat, 06/13/20 - 11:31 pm
light chain amyloidosis
JNJ
Darzalex
EHA
J&J defends Darzalex with FDA approval for faster dosing
Pharmaforum
Sun, 05/3/20 - 08:04 pm
JNJ
FDA
Darzalex
dosing
Multiple Myeloma
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Motley Fool
Mon, 02/10/20 - 11:32 pm
JNJ
Janssen
Darzalex
daratumumab
Multiple Myeloma

Pages